On 04 de nov. de 2025, PFE reported earnings of 0.87 USD per share (EPS) for Q3 25, beating the estimate of 0.63 USD, resulting in a 36.00% surprise. Revenue reached 16.65 bilhão, compared to an expected 16.74 bilhão, with a -0.53% difference. The market reacted with a -1.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analistas forecast an EPS of 0.57 USD, with revenue projected to reach 17.29 bilhão USD, implying an diminuir of -34.48% EPS, and aumentar of 3.83% in Revenue from the last quarter.
FAQ
What were Pfizer Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Pfizer Inc. reported EPS of $0.87, beating estimates by 36%, and revenue of $16.65B, -0.53% below expectations.
How did the market react to Pfizer Inc.'s Q3 2025 earnings?
The stock price moved down -1.46%, changed from $24.66 before the earnings release to $24.30 the day after.
When is Pfizer Inc. expected to report next?
The next earning report is scheduled for 02 de fev. de 2026.
What are the forecasts for Pfizer Inc.'s next earnings report?
Based on 18
analistas, Pfizer Inc. is expected to report EPS of $0.57 and revenue of $17.29B for Q4 2025.